Effects of timolol on corneal sensitivity and tear production. 1980

Y Kitazawa, and H Tsuchisaka

A double-masked study was carried out to assess the effect of timolol ophthalmic-solution on corneal sensitivity in seven normal volunteers. No significant change in corneal sensitivity was demonstrated during four weeks of timolol administration. Corneal sensitivity was determined in two age-matched groups, one comprising 27 glaucomatous patients on timolol therapy for at least three months and the other consisting of 24 normal individuals who had never been on any beta-blocking agents. No significant difference in corneal sensitivity was noted between the two groups. The tear production was determined by means of the Schirmer test I in 15 patients with primary open-angle glaucoma or ocular hypertension prior to and during timolol therapy of 13 months duration. No significant change in tear production was noted.

UI MeSH Term Description Entries
D008297 Male Males
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D003315 Cornea The transparent anterior portion of the fibrous coat of the eye consisting of five layers: stratified squamous CORNEAL EPITHELIUM; BOWMAN MEMBRANE; CORNEAL STROMA; DESCEMET MEMBRANE; and mesenchymal CORNEAL ENDOTHELIUM. It serves as the first refracting medium of the eye. It is structurally continuous with the SCLERA, avascular, receiving its nourishment by permeation through spaces between the lamellae, and is innervated by the ophthalmic division of the TRIGEMINAL NERVE via the ciliary nerves and those of the surrounding conjunctiva which together form plexuses. (Cline et al., Dictionary of Visual Science, 4th ed) Corneas
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005901 Glaucoma An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed) Glaucomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013666 Tears The fluid secreted by the lacrimal glands. This fluid moistens the CONJUNCTIVA and CORNEA. Meibomian Lipids,Meibum,Lipid, Meibomian,Meibomian Lipid,Tear
D013999 Timolol A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. (S)-1-((1,1-Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol,2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-,Blocadren,L-714,465,MK-950,Optimol,Timacar,Timolol Hemihydrate,Timolol Maleate,Timolol Maleate, (1:1) Salt,Timoptic,Timoptol,L 714,465,L714,465,MK 950,MK950

Related Publications

Y Kitazawa, and H Tsuchisaka
January 2007, Journal of diabetes and its complications,
Y Kitazawa, and H Tsuchisaka
September 2009, Investigative ophthalmology & visual science,
Y Kitazawa, and H Tsuchisaka
July 1990, The British journal of ophthalmology,
Y Kitazawa, and H Tsuchisaka
February 1984, Documenta ophthalmologica. Advances in ophthalmology,
Y Kitazawa, and H Tsuchisaka
January 2018, Veterinary ophthalmology,
Y Kitazawa, and H Tsuchisaka
December 2001, Ophthalmology,
Y Kitazawa, and H Tsuchisaka
April 1981, Archives of ophthalmology (Chicago, Ill. : 1960),
Y Kitazawa, and H Tsuchisaka
January 1980, Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Albrecht von Graefe's archive for clinical and experimental ophthalmology,
Y Kitazawa, and H Tsuchisaka
March 2020, Investigative ophthalmology & visual science,
Copied contents to your clipboard!